European Commission nod to reduced dosing frequency for Janssen Tecvayli Ruchika Sharma20 Aug 2023 11:30 AM ISTTeclistamab is an off-the-shelf (or ready to use) bispecific antibody.
Janssen bags USFDA nod for Akeega to treat prostate cancer Ruchika Sharma12 Aug 2023 11:35 AM ISTHorsham: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the U.S. Food & Drug Administration (FDA) has...
Johnson and Johnson gets USFDA accelerated nod for multiple myeloma drug Talvey Ruchika Sharma11 Aug 2023 11:29 AM ISTTALVEY is approved as a weekly or biweekly subcutaneous (SC) injection after an initial step-up phase, offering physicians the flexibility to...
Janssen seeks USFDA nod for expanded pediatric indication for HIV-1 therapy Edurant Ruchika Sharma1 Aug 2023 12:32 PM ISTTitusville: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA)...
Johnson and Johnson effort to resolve talc lawsuits in bankruptcy fails second time Ruchika Sharma31 July 2023 3:30 PM ISTUS: A U.S. judge on Friday shot down Johnson & Johnson's second attempt to resolve tens of thousands of lawsuits over its talc products in...
Anuj Virmani becomes MD of JnJ MedTech India division Ruchika Sharma25 July 2023 11:41 AM ISTMumbai: Johnson & Johnson Private Limited has announced the appointment of Anuj Virmani as the Managing Director for its Johnson & Johnson...
Baby powder suit: Johnson and Johnson must pay USD 18.8 million to California cancer patient Ruchika Sharma19 July 2023 3:57 PM ISTJohnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided...
JnJ sues in latest bid to halt Medicare drug price negotiations Ruchika Sharma19 July 2023 3:41 PM ISTJohnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government...
Phase 3 trial of Rybrevant plus chemotherapy in lung cancer meets primary endpoint: Janssen Ruchika Sharma18 July 2023 1:30 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 PAPILLON study ...
JnJ sues researchers who linked talc to cancer Ruchika Sharma14 July 2023 3:00 PM ISTNew Jersey: Johnson & Johnson has sued four doctors who published studies citing links between talc-based personal care products and cancer,...
Jurors urged to impose heavy punitive damages in JnJ talc trial Ruchika Sharma12 July 2023 4:30 PM ISTLawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson's talc-based baby powder on...
JnJ electrosurgical tools recall classified as most serious by USFDA Ruchika Sharma12 July 2023 2:30 PM ISTJ&J MedTech said during the investigation into burn injuries related to use of the devices, it was determined that in some instances the products were...
